Biopsy Devices companies

  • Report ID: 2565
  • Published Date: Sep 08, 2025
  • Report Format: PDF, PPT

Biopsy Devices Market Players:

    Companies emphasizing biopsy devices are experiencing intensified competition due to their heightened demand. Leading firms such as Becton, Dickinson and Company, Hologic, Inc., and Medtronic plc leverage several revenue-making opportunities such as product transformations, enhanced product portfolios, and strategic acquisitions to strengthen their presence in the global market landscape. For instance, BD acquired C.R. Bard, aiming to reinforce in the biopsy needle sector. Besides, the companies are readily investing in research and development with a collective goal to integrate artificial intelligence and robotics into biopsy devices, aiming to improve patient outcomes, denoting a positive market landscape.

    Some of the prominent players are listed below:

    • Becton, Dickinson and Company (BD)
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Hologic, Inc.
    • Medtronic plc
    • Olympus Corporation
    • Cook Medical
    • Cardinal Health, Inc.
    • Boston Scientific Corporation
    • Fujifilm Holdings Corporation
    • Danaher Corporation
    • Leica Biosystems
    • Argon Medical Devices, Inc.
    • B. Braun Melsungen AG
    • TransMed7, LLC
    • MDxHealth SA
    • INRAD, Inc.
    • Scion Medical Technologies LLC
    • SmartTarget Ltd.
    • Gallini Srl
    • Cook Medical LLC
    • DTR Medical

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of biopsy devices is assessed at USD 2.54 billion.

The global biopsy devices market size was valued at around USD 2.41 billion in 2025 and is projected to grow at a CAGR of more than 6.1%, reaching USD 4.36 billion revenue by 2035.

North America biopsy devices market will hold around 44.20% share by 2035, driven by advanced medical infrastructure and strong reimbursement policies.

Key players in the market include Becton, Dickinson and Company (BD), Hologic, Inc., Medtronic plc, Olympus Corporation, Cook Medical, Cardinal Health, Inc. and other.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos